EHA Endorsement of ESMO Clinical Practice Guidelines for Newly Diagnosed and Relapsed Follicular Lymphoma

EHA Endorsement of ESMO Clinical Practice Guidelines for Newly Diagnosed and Relapsed Follicular Lymphoma

Bibliographic Details
Main Authors:	Marco Ladetto, Martin Dreyling
Format:	Article
Language:	English
Published:	Wiley 2021-05-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/HS9.0000000000000559

Similar Items

EHA Endorsement of ESMO Clinical Practice Guidelines for Newly Diagnosed and Relapsed Mantle Cell Lymphoma
by: Kim Linton, et al.
Published: (2020-10-01)

EHA Endorsement of ESMO Clinical Practice Guidelines for Marginal Zone Lymphomas
by: Marco Ladetto, et al.
Published: (2020-04-01)

EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up for Waldenström’s Macroglobulinemia
by: Philipp B. Staber, et al.
Published: (2021-10-01)

EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up for Myelodysplastic Syndromes
by: Arjan A. van de Loosdrecht, et al.
Published: (2022-03-01)

EHA/ESMO Clinical Practice Guidelines for the Management of Malignant Lymphoma: Recommendations for the Second Phase of the COVID-19 Pandemic
by: Martin Dreyling, et al.
Published: (2021-02-01)

EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up of Chronic Lymphocytic Leukemia
by: Barbara Eichhorst, et al.
Published: (2021-01-01)

Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up
by: Meletios A. Dimopoulos, et al.
Published: (2021-02-01)

Correction Notice: Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up
Published: (2021-12-01)

Correction Notice: Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up
Published: (2021-04-01)

EHA Endorsement of the European Guidelines for Myelodysplastic Syndromes, MDS-RIGHT
by: Sabine Blum, et al.
Published: (2021-09-01)

Hodgkin Lymphoma: Comments on ESMO Clinical Practice Guidelines
by: Igor Aurer, et al.
Published: (2020-08-01)

EHA Endorsement of the Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia
by: Jochen Rössler, et al.
Published: (2021-11-01)

Double Hit Lymphoma Diagnosis and Treatment in Europe—A Cross-Sectional Survey of Clinical Practice by the EHA Lymphoma Working Party (EHA LyG)
by: Igor Aurer, et al.
Published: (2020-12-01)

Therapy of Newly Diagnosed Follicular Lymphoma
by: Jason R. Westin, et al.
Published: (2012-12-01)

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS
by: Muro, Kei, et al.
Published: (2019)

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS
by: Muro, Kei, et al.
Published: (2019)

Controversies in the Treatment of Follicular Lymphoma
by: Kai Hübel, et al.
Published: (2020-02-01)

Management of orphan symptoms: ESMO Clinical Practice Guidelines for diagnosis and treatment†
by: P Bossi, et al.
Published: (2020-12-01)

Genetics of Transformed Follicular Lymphoma
by: Miguel Alcoceba, et al.
Published: (2022-10-01)

Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
by: Hogendoorn, P, et al.
Published: (2010)

Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
by: Eckel, F, et al.
Published: (2011)

Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
by: Eckel, F, et al.
Published: (2010)

The role of tazemetostat in relapsed/refractory follicular lymphoma
by: Gottfried von Keudell, et al.
Published: (2021-05-01)

Modern approaches to the treatment of relapsed follicular lymphoma
by: Yu. E. Ryabukhina, et al.
Published: (2022-07-01)

The prognostic nutritional index, an independent predictor of overall survival for newly diagnosed follicular lymphoma in China
by: Jingjing Ge, et al.
Published: (2022-10-01)

Follicular lymphoma transforming to DLBCL and reverting back to follicular lymphoma at relapse—a case report
by: M. C. Suresh Babu, et al.
Published: (2020-05-01)

New Treatment Options in Advanced Stage Follicular Lymphoma
by: Kai Hübel, et al.
Published: (2018-12-01)

ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
by: Van Cutsem, E, et al.
Published: (2016)

Treatment selection for patients with relapsed or refractory follicular lymphoma
by: Alan Z. Skarbnik, et al.
Published: (2023-03-01)

EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With Cancer
by: Anna Falanga, et al.
Published: (2022-08-01)

Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
by: Casali, P, et al.
Published: (2018)

EHA Endorsement of the Global Guideline for the Diagnosis and Management of Rare Mold Infection: An Initiative of the European Confederation of Medical Mycology in Cooperation With International Society for Human and Animal Mycology and American Society for Microbiology
by: Rosanne Sprute, et al.
Published: (2021-03-01)

Guidelines for the diagnosis and treatment of follicular lymphoma in China
by: Hui-Qiang Huang
Published: (2013-03-01)

Follicular lymphoma: Saudi Lymphoma Group's clinical practice guidelines for diagnosis, management and follow-up
by: Reyad Dada, et al.
Published: (2019-01-01)

Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
by: Casali, P, et al.
Published: (2018)

Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
by: Casali, P, et al.
Published: (2018)

Follicular Lymphoma Patient Relapsing with Paraneoplastic Sensory Neuronopathy (Ganglioneuropathy)
by: Kadir Öztürk, et al.
Published: (2013-09-01)

Final Results of a Phase I/II Trial of the Combination Bendamustine and Rituximab With Temsirolimus (BeRT) in Relapsed Mantle Cell Lymphoma and Follicular Lymphoma
by: Georg Hess, et al.
Published: (2020-06-01)

Estimating the Burden of Illness of Relapsed Follicular Lymphoma and Marginal Zone Lymphoma in Ontario, Canada
by: John Kuruvilla, et al.
Published: (2023-04-01)

EHA Endorsement of the Global Guideline for the Diagnosis and Management of Rare Yeast Infections: An Initiative of the European Confederation of Medical Mycology in Cooperation With the International Society for Human and Animal Mycology and American Society for Microbiology
by: Jannik Stemler, et al.
Published: (2021-10-01)